A Multicenter, Randomized, Double-Blind, Placebo controlled Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Participants living with Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection on Antiretroviral Treatment
Date:
12/01/2024
Topics:
Lead Investigators:
Summary
No summary available